A few years back Isonea (now called RSH) reached $200m m/c on its wheeze device for Asthma, you had to buy this external device and attach it to your phone to get a reading.... If Isonea could reach $200m m/c then I certainly dont see why RAP cannot reach that and better it considering there is a much broader market for RAP's tech and no external device required....
30c = what Isonea reached.....
Ann: Breakthrough Performance in Paediatric Clinical Study, page-37
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
